Lessons learned from recruiting into a longitudinal remote measurement study in major depressive disorder
Year: 2022
Type: review
Abstract: The use of remote measurement technologies (RMTs) across mobile health (mHealth) studies is becoming popular, given their potential for providing rich data on symptom change and indicators of future state in recurrent conditions such as major depressive disorder (MDD). Understanding recruitment into RMT research is fundamental for improving historically small sample sizes, reducing loss of statistical power, and ultimately producing results worthy of clinical implementation. There is a need for the standardisation of best practices for successful recruitment into RMT research. The current paper reviews lessons learned from recruitment into the Remote Assessment of Disease and Relapse- Major Depressive Disorder (RADAR-MDD) study, a large-scale, multi-site prospective cohort study using RMT to explore the clinical course of people with depression across the UK, the Netherlands, and Spain. More specifically, the paper reflects on key experiences from the UK site and consolidates these into four key recruitment strategies, alongside a review of barriers to recruitment. Finally, the strategies and barriers outlined are combined into a model of lessons learned. This work provides a foundation for future RMT study design, recruitment and evaluation.
Source: npj Digital Medicine
Institutions: King's College London, South London and Maudsley NHS Foundation Trust, Amsterdam Public Health, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Centro de Investigación Biomédica en Red de Salud Mental, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Lundbeck (Denmark), Northwestern University, University of Sussex
Language: English
Subfield: Applied Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,290
Funders: South London and Maudsley NHS Foundation Trust, European Federation of Pharmaceutical Industries and Associations, National Institute for Health and Care Research, Department of Health and Social Care, King's College London, European Commission, Innovative Medicines Initiative, NIHR Maudsley Biomedical Research Centre
OpenAlex ID: W4294391267
